Navigation Links
Kensey Nash to Participate in the RBC Capital Markets Healthcare Conference
Date:12/7/2007

EXTON, Pa., Dec 7 /PRNewswire-FirstCall/ -- Kensey Nash Corporation (Nasdaq: KNSY) is scheduled to participate in a panel discussion on "Helping the Body Regenerate Bone & Tissue" at the 2007 RBC Capital Markets Healthcare Conference.

Douglas G. Evans, Kensey Nash's COO, will participate in the panel discussion on Thursday, December 13th at 8:00 a.m. ET in The Westin New York at Times Square in New York. The conference is by invitation only, however individuals can listen to the live and archived presentation at http://www.wsw.com/webcast/rbc84/panel20 or by visiting the Company's website (http://www.kenseynash.com).

About Kensey Nash Corporation. Kensey Nash Corporation is a leading medical technology company providing innovative solutions and technologies for a wide range of medical procedures. The Company provides an extensive range of products into multiple medical markets, primarily in the endovascular, sports medicine and spine markets. Many of the products are based on the Company's significant expertise in the design, development, manufacturing and processing of absorbable biomaterials, which has led to partnerships to commercialize technologies. Kensey Nash has also commercialized a series of innovative products through its own direct endovascular sales force. The Company is known as a pioneer in the field of arterial puncture closure, as the inventor and developer of the Angio-Seal(TM) Vascular Closure Device, which is licensed to St. Jude Medical, Inc.


'/>"/>
SOURCE Kensey Nash Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Kensey Nash to Present at the Sidoti Sixth Annual West Coast Emerging Growth Institutional Investor Forum Conference
2. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
3. Boston Scientific to Participate in the Bear Stearns 20th Annual Healthcare Conference
4. China Medical Technologies to Participate in Credit Suisses 2007 Asian Technology Conference
5. Angiotech to participate in UBS Global Life Sciences Conference
6. Transcept Pharmaceuticals to Participate in Middle-of-the-Night (MOTN) Insomnia Investor Panel
7. Vicus Therapeutics Chief Executive Officer to Participate in BIOTECH 2007 Expert Panels
8. Genzyme to Participate in FDA Advisory Committee Meeting on the Use of Phosphate Binders in Chronic Kidney Disease
9. MacroChem To Participate in PIPEs Conference October 18th and 19th in New York City
10. Lev Pharmaceuticals Invites You to Participate in its Q307 Earnings Results Conference Call and Webcast
11. Angiotech to participate in Bank of America 2007 Credit Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2018)... EVANSTON, Ill. (PRWEB) , ... November 05, 2018 ... ... Technologies Inc., for access to 2Blades’ Transcription Activator Like (TAL) effector code technology ... rights for commercial uses of the technology in plants. Since its discovery in 2009, ...
(Date:11/3/2018)... ... ... Triangle Insights Group, a premier life sciences consulting firm, announced today that it ... United States, appearing on this year’s Inc. 5000 list. Since its inception in ... the previous three years. , Separately, Triangle Insights was also ranked on Consulting ...
(Date:10/31/2018)... ... October 30, 2018 , ... Myoscience, Inc. ... the Campbell Clinic in Memphis, Tennessee. This study enrolled 125 patients and ... care for managing pain after total knee replacement surgery (TKA). , The Myoscience ...
(Date:10/31/2018)... ... October 30, 2018 , ... ... be a very important aspect of experimental biology. Reproducibility of cell-based assays is ... Despite of choosing the appropriate assay type, there are many more factors to ...
Breaking Biology Technology:
(Date:12/5/2018)... NEW YORK (PRWEB) , ... December 03, 2018 ... ... with Cartessa Aesthetics , an emerging leader in the distribution and marketing ... has experienced rapid growth, projecting $20MM in sales for 2018. Cartessa’s success ...
(Date:12/5/2018)... ... December 04, 2018 , ... ... and existing IP in the development of innovative solutions for which high-speed imaging ... diverse systems from microfluidics to industrial machinery and instrumentation, allowing partner companies to ...
(Date:11/27/2018)... Mo. (PRWEB) , ... November 26, 2018 , ... PulseEd™ ... use of low-intensity, high-frequency sound waves to stimulate blood flow to the penis. Regular ... become clogged with age, is necessary for good erectile function. The recorded results of ...
Breaking Biology News(10 mins):